3DBio has developed unique capabilities that enable the creation of living tissue implants for therapeutic applications.
The 3DBio technology platform is unique because it creates living tissue implants with exceptional performance and was purpose-built to meet the FDA’s requirements for therapeutic manufacturing. The platform includes novel and proprietary 3D-bioprinter (GMPrint™), bio-ink (ColVivo™), specialized cell culture system and implantable protective shell (Overshell Technology).
ColVivo™ – Therapeutic-grade bio-ink
ColVivo™ is a therapeutic-grade bio-ink platform, developed and manufactured by 3DBio, specifically for therapeutic applications of 3D-bioprinting. The bio-ink was created to meet cGMP processing requirements for therapeutic use, while preserving key biological and rheological properties essential for 3D-bioprinting. As a bio-ink, ColVivo™ carries living cells within it and is shaped into living implants in conjunction with the GMPrint™ 3D-bioprinter.
Proprietary Cell Processes
3DBio has deep expertise in cell extraction, expansion, and storage processes, in addition to its capabilities in 3D-bioprinters and materials. 3DBio has developed its own proprietary processes to ensure that, before incorporation into the bio-ink, the cells are rapidly expanded in sufficient quantity while maintaining appropriate functionality, throughout the printing process as well as when the tissues are implanted.